10.07

10.07 (0.49%)

As of Mar 01, 2024

CURIS INC [CRIS]

Source: 

Company Overview

Curis Inc is a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase, or IRAK4.

CountryUS
Headquarterslexingtonmassachusetts
Phone Number(617) 503-6500
Industrybiological products (no diagnostic substances)
CEOJames Dentzer
Websitewww.curis.com